fda statement bpc-157 compounding safety risks panel backs compounded BPC-157, KPV peptides in win for RFK Jr BIG NEWS FOR BPC 157
BIG NEWS FOR BPC 157 Today, the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy FDA is reviewing seven peptides this week, BPC 157, MOTS c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter restrictions on compounding pharmacies. Read past the headline FDA to review 7 popular peptides touted for weight loss, healing and longevity An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition What to Know About Peptides the FDA Is Considering for Use The New York Times
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17


